Google
SIGA — SIGA TECHNOLOGIES INC (Healthcare >> Drug Manufacturers - Specialty & Generic)
SIGA FAQ
What is SIGA's P/E ratio?
SIGA TECHNOLOGIES INC (SIGA) currently trades at a P/E ratio of 8.69.
What is SIGA's ROE?
SIGA TECHNOLOGIES INC reports a Return on Equity (ROE) of 13.36%.
What is SIGA's dividend yield?
SIGA TECHNOLOGIES INC offers a dividend yield of 0.00%.
What is SIGA's Deepscope Quality Score?
Deepscope rates SIGA's overall financial quality at 62 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy SIGA?
Deepscope's AI Timing Score for SIGA is 26 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does SIGA belong to?
SIGA TECHNOLOGIES INC is classified under the Healthcare >> Drug Manufacturers - Specialty & Generic sector on the NASDAQ exchange.
|
USD 4.30
Price
-0.13
(-2.93%)
Day Change
|
|
|---|
SIGA, the overall quality is ok ( Quality = 62) and the timing to buy is ...(Sign In to See)...
Loading chart...
- Signal
- NEUTRAL
- Signal Description
- Company financial health is OK
- Reason
-
Acceleration of ROE growth rate is below our criteria.
Negative growth of ROE in the last year.
Acceleration of ROA growth rate is below our criteria.
Growth of ROA was below our criteria in the last year.
Acceleration of net profit margin growth rate is below our criteria
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
In details, quality factors are not quite good , financial health is not good , and ability to make profit is good , ...
| Quality Factors |
|
54% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 99 |
| Magic Formula Rank by ROA |
287
|
| Magic Formula Rank by ROE |
287
|
| Magic Formula Rank by ROIC |
126
|
| Price | 4.30 |
| PBV / Sector |
2.03 / 2.76
|
| Earning Per Share | 0.28 |
| PE / Sector |
8.69 / 23.64
GREAT
|
| PEG or PE/Growth / Sector |
0.81 / 0.13
|
| Average 1M Daily Value |
2.41 M
GREAT
|
| Average 1W Daily Value |
1.78 M
GREAT
|
| Timing Factors |
|
14% |
| Financial Health |
|
41% |
| Ability to Make Profit |
|
72% |
| Return to Investors |
|
70% |
| Registration Details |
| Analyze Date | 2026-06-06 09:09:09 |
| Symbol | SIGA |
| Name | SIGA TECHNOLOGIES INC |
| Sector | Healthcare >> Drug Manufacturers - Specialty & Generic |
| Market | NASDAQ |
| Listed Shares | 71.72 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 308.41 / 9,835.56 |
| News, Concensus, ... |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 31 East 62nd Street, New York, NY, United States, 10065
Phone: 212 672 9100
Website: https://www.siga.com
Sector: Healthcare >> Drug Manufacturers - Specialty & Generic
Description: SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security market in the United States. The company's lead product is TPOXX, an antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. was incorporated in 1995 and is headquartered in New York, New York.
ME vs SECTOR Healthcare >> Drug Manufacturers - Specialty & Generic
Click a bubble to view stock details · Bubble size represents market capitalization share
